Please login to the form below

Not currently logged in
Email:
Password:

Chugai appoints Ruth Currie as MD of its UK business

She replaces John Halls, who has been promoted

Ruth Currie, Chugai UKChugai Pharmaceuticals has promoted Ruth Currie to managing director of its UK business.

Currie takes over from John Halls, who also receives a promotion that sees him become managing director for Chugai's commercial activities across Europe.

In her new role, Currie will oversee all UK commercial operations of Chugai, which has been a subsidiary of Roche since 2002. She will also join Chugai's European leadership team.

Currie has been with Chugai, the original developers of RoAcemtra, since 2009, holding several senior positions, including most recently as UK sales director.

11th February 2013

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M3 (EU)

M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...

Latest intelligence

Where next in Alzheimer’s disease R&D?
How past failures and emerging biology are reshaping drug development...
Brain scan
Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...

Infographics